Skip to content

Effect of Navaka guggulu and Rasanjana ghanvati in Sthaulya

A comparative pharmaceutico analytical and clinical study of navaka guggulu and rasanjana ghanvati in sthaulya w.s.r to obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018149
Enrollment
40
Registered
2019-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Group A: Navaka Guggulu 1gm TDS for 90 Days Control Intervention1: Group B: Rasanjana Ghanvati 500mg TDS for 90 Days

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. clinical signs and symptoms of sthaulya. 2. bmi > 25kg/square meter

Exclusion criteria

Exclusion criteria: 1. patient with hypothyroidism and cushing syndrome 2. patient with long term steroid treatment 3. patient with severe hypertension. 4. patient with evidence of renal, hepatic and cardiac involvement 5. patient with DM.

Design outcomes

Primary

MeasureTime frame
It will be carried out at interval of 30 Days till completion of trial(90 days) 2. will be carried out before , during and after the treatment. 3. Assessment will be done statistically. 4. Any addition or exclusion may be included as per necessity of the study.Timepoint: It will be carried out at interval of 30 Days till completion of trial(90 days) 2. will be carried out before , during and after the treatment. 3. Assessment will be done statistically. 4. Any addition or exclusion may be included as per necessity of the study.

Secondary

MeasureTime frame
exacaberation in signs and symptomsTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Usha Sharma

Department of Rasa Shatra & Bhaishajya Kalpana Rishikul campus, U.A.U, Haridwar

ushaojha62@gmail.com9219618264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026